Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Clària

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Gastroenterologia Y Hepatologia|June 1, 1997
[Selective inhibitors of COX-2: new anti-inflammatory agents without gastric-damaging effects]J Clària
Gut|November 16, 2001
Sodium in preascitic cirrhosis: please pass the saltJ Clària, J Rodés
Gut|October 13, 1999
Renal sodium handling in pre-ascitic cirrhosisJ Clària, J Rodés
Gut|May 5, 2001
Renal sodium handling in preascitic cirrhosisJ Clària, J Rodés
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 12, 2005
Liver: the formation and actions of aspirin-triggered lipoxinsJ Clària, A Planagumà
Current Pharmaceutical Design|October 28, 2005
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancerJ Clària, M Romano
Gastroenterologia Y Hepatologia|April 2, 2004
[Kupffer cell]J Clària, E Titos
Proceedings of the National Academy of Sciences of the United States of America|October 10, 1995
Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactionsJ Clària, C N Serhan
Current Topics in Medicinal Chemistry|February 20, 2007
New approaches to the modulation of the cyclooxygenase-2 and 5-lipoxygenase pathwaysA González-Périz, J Clària
Gastroenterologia Y Hepatologia|November 1, 1996
[Aquaretic agents]M Bosch-Marcé, J Clària, W Jiménez
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Gastroenterologia Y Hepatologia|June 1, 1997
[Selective inhibitors of COX-2: new anti-inflammatory agents without gastric-damaging effects]J Clària
Gut|November 16, 2001
Sodium in preascitic cirrhosis: please pass the saltJ Clària, J Rodés
Gut|October 13, 1999
Renal sodium handling in pre-ascitic cirrhosisJ Clària, J Rodés
Gut|May 5, 2001
Renal sodium handling in preascitic cirrhosisJ Clària, J Rodés
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 12, 2005
Liver: the formation and actions of aspirin-triggered lipoxinsJ Clària, A Planagumà
Current Pharmaceutical Design|October 28, 2005
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancerJ Clària, M Romano
Gastroenterologia Y Hepatologia|April 2, 2004
[Kupffer cell]J Clària, E Titos
Proceedings of the National Academy of Sciences of the United States of America|October 10, 1995
Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactionsJ Clària, C N Serhan
Current Topics in Medicinal Chemistry|February 20, 2007
New approaches to the modulation of the cyclooxygenase-2 and 5-lipoxygenase pathwaysA González-Périz, J Clària
Gastroenterologia Y Hepatologia|November 1, 1996
[Aquaretic agents]M Bosch-Marcé, J Clària, W Jiménez
Pageof 5